ADMA Biologics Inc (ADMA)
9.215
+0.16
(+1.71%)
USD |
NASDAQ |
May 17, 16:00
9.21
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics Market Cap: 2.135B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 2.135B |
| May 16, 2024 | 2.100B |
| May 15, 2024 | 2.109B |
| May 14, 2024 | 2.123B |
| May 13, 2024 | 2.038B |
| May 10, 2024 | 2.042B |
| May 09, 2024 | 1.606B |
| May 08, 2024 | 1.590B |
| May 07, 2024 | 1.602B |
| May 06, 2024 | 1.602B |
| May 03, 2024 | 1.579B |
| May 02, 2024 | 1.562B |
| May 01, 2024 | 1.546B |
| April 30, 2024 | 1.511B |
| April 29, 2024 | 1.525B |
| April 26, 2024 | 1.518B |
| April 25, 2024 | 1.493B |
| April 24, 2024 | 1.497B |
| April 23, 2024 | 1.516B |
| April 22, 2024 | 1.437B |
| April 19, 2024 | 1.453B |
| April 18, 2024 | 1.437B |
| April 17, 2024 | 1.400B |
| April 16, 2024 | 1.428B |
| April 15, 2024 | 1.386B |
| Date | Value |
|---|---|
| April 12, 2024 | 1.395B |
| April 11, 2024 | 1.442B |
| April 10, 2024 | 1.400B |
| April 09, 2024 | 1.416B |
| April 08, 2024 | 1.442B |
| April 05, 2024 | 1.481B |
| April 04, 2024 | 1.456B |
| April 03, 2024 | 1.472B |
| April 02, 2024 | 1.493B |
| April 01, 2024 | 1.516B |
| March 28, 2024 | 1.506B |
| March 27, 2024 | 1.538B |
| March 26, 2024 | 1.483B |
| March 25, 2024 | 1.458B |
| March 22, 2024 | 1.436B |
| March 21, 2024 | 1.413B |
| March 20, 2024 | 1.442B |
| March 19, 2024 | 1.413B |
| March 18, 2024 | 1.356B |
| March 15, 2024 | 1.367B |
| March 14, 2024 | 1.374B |
| March 13, 2024 | 1.429B |
| March 12, 2024 | 1.420B |
| March 11, 2024 | 1.410B |
| March 08, 2024 | 1.447B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
129.52M
Minimum
Mar 18 2020
2.135B
Maximum
May 17 2024
479.81M
Average
284.08M
Median
May 29 2020
Market Cap Benchmarks
| Vanda Pharmaceuticals Inc | 318.93M |
| ANI Pharmaceuticals Inc | 1.288B |
| Ligand Pharmaceuticals Inc | 1.546B |
| Johnson & Johnson | 372.17B |
| Puma Biotechnology Inc | 197.54M |
Market Cap Related Metrics
| PS Ratio | 7.402 |
| Price to Book Value | 13.89 |
| Price to Free Cash Flow | 131.77 |
| Price | 9.215 |
| Earnings Yield | -0.22% |
| Operating PE Ratio | 47.35 |
| Normalized PE Ratio | 96.12 |